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ABSTRACT
DNAsingle-strandbreakscontaining30-8-oxoguanine
(30-8-oxoG) ends can arise as a consequence of
ionizing radiation and as a result of DNA polymerase
infidelity by misincorporation of 8-oxodGMP. In this
study we examined the mechanism of repair of
30-8-oxoG within a single-strand break using purified
base excision repair enzymes and human whole cell
extracts. We find that 30-8-oxoG inhibits ligation by
DNA ligase IIIa or DNA ligase I, inhibits extension
by DNA polymerase b and that the lesion is resistant
toexcisionbyDNAglycosylasesinvolvedintherepair
of oxidative lesions in human cells. However, we
find that purified human AP-endonuclease 1 (APE1)
is able to remove 30-8-oxoG lesions. By fractionation
of human whole cell extracts and immunoprecipi-
tation of fractions containing 30-8-oxoG excision
activity, we further demonstrate that APE1 is the
major activity involved in the repair of 30-8-oxoG
lesions in human cells and finally we reconstituted
repair of the 30-8-oxoG-containing oligonucleotide
duplex with purified human enzymes including
APE1, DNA polymerase b and DNA ligase IIIa.
INTRODUCTION
Ionizing radiation produces DNA lesions largely through the
generation of reactive oxygen species (ROS) that attack
DNA (1). The same types of ROS are generated endogenously
as by-products of oxidative metabolism and during the inﬂam-
matory response in non-irradiated cells. ROS can induce oxid-
ative DNA damage, such as 8-oxoguanine (8-oxoG), directly
or can oxidize nucleotide triphosphates that can be later incor-
porated into DNA (2). Furthermore, several events may lead to
the formation of DNA lesions containing 30-terminal 8-oxoG
residues. For example during base excision repair (BER), mis-
incorporation of 8-oxodGMP by DNA polymerase b lacking
proofreading activity may generate a 30-terminal 8-oxoG (3,4).
If this 30-terminal 8-oxoG does affect ligation of the neigh-
bouring phosphodiester bond, then it will result in persistent
DNA containing single-strand breaks (SSBs) with 30-terminal
8-oxoG ends. Similar lesions may also arise as a result of so-
called ‘clustered lesions’, since ionizing radiation energy is
deposited in small volumes of nanometre dimensions resulting
in ROS being produced at high local concentrations (5). Con-
sequently, the formation of multiply damaged sites in DNA
may include 30-8-oxoG lesions immediately next to a SSB.
Normally 8-oxoG, as with many other base lesions in DNA,
is efﬁciently repaired by the BER pathway (6,7). However,
little is known about the repair of base lesions located in close
proximity toDNA strand breaks, although earlyﬁndings indic-
ated that repair enzymes could inefﬁciently process such
lesions. For example, uracil-DNA glycosylase inefﬁciently
removes uracil residing at the 30-end of oligonucleotides (8)
and DNA polymerase b, the major base excision repair
polymerase, very inefﬁciently extends a primer containing
30-terminal 8-oxoG (3,9). Therefore, the mechanism for the
repair of 30-terminal 8-oxoG lesions is unclear although there
are several repair pathways that have the potential to process
these 30-blocking lesions, including direct excision of the 30-
terminal 8-oxoG by DNA glycosylase activity or a speciﬁc 30-
end processing activity that would excise the modiﬁed nucle-
otide. This would be followed by the repair of the intermediate
product arising by proteins of the BER pathway.
In this study, we use oligonucleotide duplexes containing
a site-speciﬁc lesion and human whole cell extracts to
address the mechanism of repair of 30-8-oxoG lesions within
a DNA SSB.
MATERIALS AND METHODS
Materials
Synthetic oligodeoxyribonucleotides were purchased from
MWG-Biotech and gel puriﬁed on a 20% polyacrylamide gel.
[g-
32P]ATP (3000 Ci/mmol) was purchased from PerkinElmer
Life Sciences. Human AP-endonuclease 1 (APE1), Pol b and
DNA ligase IIIa were puriﬁed as described previously (10).
His-tagged OGG1 and DNA ligase IIIa were puriﬁed on a
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and NEIL2 were kindly provided by D. Zharkov and DNA
ligase I was a gift from A. Tomkinson. Antibodies against
human APE1 were raised in rabbit and afﬁnity puriﬁed as
described (11).
Substrate labelling
Oligonucleotides were 50-end labelled with [g-
32P]ATP using
T4-polynucleotide kinase and unincorporated label removed
on a Sephadex G-25 spin column. To prepare the 30-8-oxoG
substrate, the oligonucleotides 50-CCTGCAGGTCGAC-
TCTAGA
8OXOG-30 and 50-GCCGGCCGATCAAGCTTATT
GGGT-30 were annealed to a 2-fold excess of the oligonuc-
leotide 50-ACCCAATAAGCTTGATCGGCCGGCCTCTAG-
AGTCGACCTGCAGG-30 (8-oxoG/C) or 50-ACCCAATAA-
GCTTGATCGGCCGGCATCTAGAGTCGACCTGCAGG-30
(8-oxoG/A) at 90 C for 3–5 min followed by slow cooling to
room temperature. To prepare the control containing substrate,
the oligonucleotide 50-CCTGCAGGTCGACTCTAGAG-30
replaced the 8-oxoG containing oligonucleotide.
Fractionation of cell extracts
HeLa cell pellets were purchased from Paragon, USA. Whole
cell extracts (WCEs) were prepared by the method of Manley
et al. (12) dialysed overnight against buffer containing 25 mM
HEPES–KOH, pH 7.9, 100 mM KCl, 12 mM MgCl2, 0.1 mM
EDTA, 17% glycerol and 2 mM DTT and aliquots frozen at
 80 C for the repair assays. An aliquot of this extract (100 mg
protein) was then fractionated by Phosphocellulose chroma-
tography using a step elution of 150 mM KCl (PC-FI) and 1 M
KCl(PC-FII)aspreviouslydescribed(13,14).Proteins(10mg)
from the PC-FII fraction were further separated by gel ﬁltra-
tion on a Superdex-75 column (Amersham) in a buffer con-
taining 50 mM HEPES (pH 7.9), 150 mM KCl, 1 mM EDTA,
1 mM DTT and 1 mM phenylmethylsulphonyl ﬂuoride. 0.5 ml
fractions were collected and tested for the ability to remove
30-8-oxoG as described below.
Repair assays using purified enzymes
Assays using puriﬁed proteins contained 250 fmol oligo-
nucleotide per reaction in 20 ml Reaction buffer containing
50 mM HEPES–KOH, pH 7.8, 50 mM KCl, 10 mM MgCl2,
0.5 mM EDTA, 1.5 mM DTT, 8.5% glycerol and 100 mg/ml
BSA. Primer extension and in vitro reconstitution reactions
also included 20 mM of each dCTP, dATP, dGTP and TTP. All
reactions were incubated for the time indicated at 37 C and
20 ml formamide loading dye (95% formamide, 0.02% xylene
cyanole, 0.02% bromophenol blue) added and the samples
heated to95 Cfor5min.Productswere subsequentlyanalysed
by 20% denaturing PAGE and gels exposed to intensifying
screens at 4 C prior to analysis by phosphorimaging.
Excision and repair of 30-8-oxoG by cell extracts
Excision assays contained 250 fmol oligonucleotide per reac-
tion in 20 ml reaction buffer containing 50 mM HEPES–KOH,
pH 7.8, 50 mM KCl, 10 mM MgCl2, 0.5 mM EDTA, 1.5 mM
DTT, 8.5% glycerol, 2 mM ATP, 25 mM phosphocreatine
(diTris salt, Sigma), 2.5 mg creatine phosphokinase (type I,
Sigma), 0.25 mM NAD
+ and 1 mg of carrier DNA (single
stranded 30mer oligonucleotide). Repair reactions also
included 20 mM of each dNTPs. Reactions were incubated
for the time indicated at 37 C, 20 ml formamide loading
dye added and samples heated to 95 C for 5 min. Products
were subsequently analysed by 20% denaturing PAGE and
gels exposed to intensifying screens at 4 C prior to analysis
by phosphorimaging.
Immunodepletion of APE1
Protein A Sepharose CL-4B was allowed to swell for 1 h in
phosphate-buffered saline (PBS) and following washes with
PBS a 50%-suspension was prepared. To 100 ml suspension
was added 5 ml APE1 antibodies or 5 ml pre-immune serum
and incubation was carried out for 2 h at 4 C with gentle
shaking. The APE1-Sepharose was washed ﬁve times with
0.3 ml PBS and resuspended in 100 ml PBS. Fractions puriﬁed
from Phosphocellulose and gel ﬁltration chromatography
(20 ml) were mixed with 20 ml APE1-Sepharose and incubated
for 2 h at 4 C with gentle shaking. The mixture was ﬁltered
through Spin-X columns at 4 C and aliquots taken and SDS-
PAGE loading dye (25 mM Tris–HCl, pH 6.8, 2.5% mercap-
toethanol, 1% SDS, 5% glycerol, 1 mM EDTA, 0.15 mg/ml
bromophenol blue) added. The samples were heated to 90 C
for 3 min prior to loading on a 10% SDS–polyacrylamide gel
followed by transfer to a PVDF membrane and immunoblot
analysis with the indicated antibodies. Aliquots were also
taken for 30-8-oxoG repair assays as described above.
RESULTS
30-8-oxoG residues inhibit ligation by DNA ligases and
processing by DNA polymerase b or DNA glycosylases
The easiest way to process 30-8-oxoG isto remove it by a DNA
glycosylase activity. To test for DNA glycosylase activities
towards 30-8-oxoG residues, the 30-8-oxoG containing oligo-
nucleotide was 50-labelled prior to construction of the nick
containing duplex oligonucleotide (Figure 1A). This substrate
20-8-oxoG
OGG1 NEIL1 NEIL2
1       2         3       4         5       6
A
5'-CCTGCAGGTCGACTCTAGAGGCCGGCCGATCAAGCTTATTGGGT-3'
3'-GGACGTCCAGCTGAGATCTCCGGCCGGCTAGTTCGAATAACCCA-5'
5
'
-
P
3'-OH
B
Figure 1. ThehumanDNA glycosylases OGG1,NEIL1and NEIL2are unable
to excise 30-8-oxoG lesions. (A) Schematic representation of the 30-8-oxoG
containing oligonucleotide substrate within a SSB. Underlined bold G stands
for 8-oxodG. (B) The 20mer 30-8-oxoG containing oligonucleotide substrate
(20-8oxoG, 0.25 pmol) was incubated with OGG1, NEIL1 or NEIL2 (2.6, 2.6
and 2.3 pmol, respectively) for 20 min at 37 C prior to the addition of
formamide loading dye with (lanes 1, 3 and 5) or without (lanes 2, 4 and 6)
100mMNaOH.Sampleswereheatedto95 Cfor5minpriortoanalysisby20%
denaturing PAGE and phosphorimaging.
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of either human 8-oxoguanine DNA glycosylase (OGG1) or
human endonuclease VIII-like proteins (NEIL1, NEIL2).
Although the activity of all enzymes had been tested with the
correspondingsubstrates(datanotshown),noexcisionactivity
against 30-8-oxoG lesions could be observed (Figure 1B).
Furthermore, on addition of sodium hydroxide to cleave
any abasic sites generated by DNA glycosylase activity no
cleavage products were observed indicating that, at the con-
centrations used,DNA glycosylase activities ofOGG1,NEIL1
or NEIL2 are not active against 30-8-oxoG residues.
Another opportunity to process 30-8-oxoG would be to
convert it to a conventional 8-oxoG by sealing the SSB and
then repair it through the BER pathway. To investigate this
possibility, a radiolabelled duplex oligonucleotide substrate
containing a 50-phosphorylated nick with 30-8-oxoG ends
was constructed (Figure 1A). The ability of DNA ligase IIIa
and DNA ligase I to ligate this substrate was then compared
to the corresponding control oligonucleotide containing
30-guanine. The control duplex oligonucleotide was gradually
ligated by increasing concentrations of DNA ligase to the
corresponding 44mer oligonucleotide (Figure 2A and 2B,
right panel). However the 30-8-oxoG containing oligonuc-
leotide is non-ligatable, even at the highest amount of DNA
ligase used (Figure 2A and 2B, left panel).
Another possibility for removing 30-8-oxoG lesions would
be to extend the 30-end by DNA polymerase synthesis
and afterwards repair 8-oxoG through the BER pathway. To
investigate such a possibility, a substrate containing the 20mer
50-labelled 30-8oxoG lesion annealed to the 44mer comple-
mentary oligonucleotide was generated to analyse the ability
of Pol b (the major BER polymerase) to extend the 30-8-oxoG
containing primer. With a control oligonucleotide substrate,
primer extension is achieved by increasing concentrations
of Pol b (Figure 3, right panel). However, under the same
conditions the 30-8-oxoG containing substrate is resistant to
primer extension synthesis by Pol b (Figure 3, left panel).
These experiments show that 30-8-oxoG residues are non-
ligatable, resistant to DNA glycosylase activities and are
not extended by Pol b, and indicate a speciﬁc repair enzyme
for the removal of 30-8-oxoG residues. It has been previously
shown that APE1 has 30-exonuclease activity that is involved
in the removal of 30-end mismatched nucleotides (15) and
therefore we tested the possibility of puriﬁed APE1 being
capable of excising 30-8-oxoG lesions. With the use of a
control nick containing duplex oligonucleotide (30-G/C) or
mismatch containing duplex (G/A), no signiﬁcant exonuclease
activity of APE1 was observed in our reaction conditions
(Figure 4A and B; left panel). In comparison, using a 30-8-
oxoG nick containing duplex oligonucleotide substrate with
8-oxoguanine opposite cytosine (30-8oxoG/C) or adenine
(30-8oxoG/A), APE1 processed the 30-end speciﬁcally
removing the 8-oxoG lesion only to generate a 19mer product
(Figure 4Aand B; right panel) and demonstrates the 30-8-oxoG
speciﬁc end processing activity of APE1.
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3'-G/C 3'- 8oxoG/C
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Figure 2. An oligonucleotide containing 30-8-oxoG within a SSB cannot
be ligated by DNA ligase IIIa or DNA ligase I. 250 fmol of the 30-8-oxoG
containing (left panel) or a control duplex oligonucleotide substrate (right
panel) were incubated with DNA ligase IIIa (A) or DNA ligase I (B) for
20 min at 37 C prior to the addition of formamide loading dye. An aliquot
was analysed by 20% denaturing PAGE and phosphorimaging.
20-mer
Pol β fmol
3'-G/C 3'-8oxoG/C
0     100    200    400      0     100     200    400
Extension 
products
Figure 3. An oligonucleotide containing 30-8-oxoG ends is resistant to primer
extension by DNA polymerase b. 250 fmol of the 30-8-oxoG containing (left
panel) and a control duplex oligonucleotide substrate (right panel) were
incubated with DNA polymerase b (0–400 fmol) for 20 min at 37 C prior
to the addition of formamide loading dye. An aliquot was analysed by 20%
denaturing PAGE and phosphorimaging.
20-mer
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APE1, fmol
3'-8-oxoG/C 3'-G/C
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Figure 4. APE1 excises 30-8-oxoG lesions present within a SSB. 250 fmol of
the duplex oligonucleotide substrate containing 30-8-oxoG opposite to C (30-8-
oxoG/C;A,rightpanel)orA(30-8-oxoG/A;B,rightpanel)andacontrolduplex
containing 30-G/C base pair (A, left panel) or 30-G/A mismatch (B, left panel)
wereincubatedwithAPE1(0–600fmol)for20minat37 Cpriortotheaddition
of formamide loading dye. An aliquot was analysed by 20% denaturing PAGE
and phosphorimaging.
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from human WCE
Although we showed that puriﬁed APE1 is able to cleave
30-8-oxoG residues, we tested human WCE for the ability
to repair this lesion and subsequently isolated the major activ-
ity against 30-8-oxoG. Using HeLa WCE, we were able to
demonstrate the repair of 30-8-oxoG residues when present
within a nick, although with low efﬁciency. Incubation with
WCE converted the 20mer30-8-oxoGcontaininglabelled frag-
ment of the oligonucleotide substrate, shown in Figure 1A, to
the full-length repaired 44mer product, indicating the 30-8-
oxoG excision activity in WCE (Figure 5A). We proceeded
tofurthercharacterizethe30-8-oxoGactivityfromhumanWCE
using Phosphocellulose chromatography, eluting proteins off
into two fractions using low (0.15 M KCl, PC-FI) and high salt
(1 M KCl, PC-FII) elution (13,14). These fractions were tested
for their ability to remove 30-8-oxoG lesions and we ﬁnd that
the majority of the 30-8-oxoG activity observed in human
WCE is retained in the high salt elution fraction PC-FII
only (Figure 5B; fourth panel), which has also been found to
contain the majority of BER proteins, including APE1 (7).
No other residual activity for the removal of 30-8-oxoG was
observed in the low salt fraction PC-FI (Figure 5B; third
panel). The proteins within fraction PC-FII, which contained
the major 30-8-oxoG excision activity, were further separated
according to their size by gel ﬁltration chromatography.
The fractions were subsequently tested for their ability to
remove 30-8-oxoG lesions and it was shown that the activity
was present predominantly within fractions 19–23, where
proteins with a molecular weight of  40–60 kDa are eluted
(Figure 5C). Western blot analysis of these fractions revea-
led that elution of APE1 occurred within fractions 19–23
(Figure 5D) so we conclude that the 30-8-oxoG cleavage activ-
ity co-puriﬁes with APE1 protein.
Co-precipitation of APE1 and 30-8-oxoG activity
Gel ﬁltration fractions containing the peak of 30-8-oxoG
excision activity (fractions 20 and 21) were chosen to immun-
odeplete APE1 using antibodies raised against APE1. Analysis
by western blot reveals that, although the levels of APE1 are
slightly reduced by mock immunodepletion compared to the
original fractions, using APE1 antibodies the fractions were
completely depleted of the APE1 protein (Figure 6A). The
original fractions, alongside the mock immunodepleted and
immunodepleted fractions, were subsequently tested for their
ability to remove 30-8-oxoG lesions. The mock immunodeple-
tion protocol does not affect 30-8-oxoG cleavage activity in
fractions 20 and 21 (Figure 6B, lanes 4 and 5) compared to the
original fractions (Figure 6B, lanes 2 and 3). However, using
antibodies speciﬁc to APE1, the activity against 30-8-oxoG is
completely ablated (Figure 6B, lanes 6 and 7). Taken together,
these results indicate that APE1 is the major enzyme pro-
cessing 30-8-oxoG lesions in human cell extracts.
Finally, we reconstituted repair of the 30-8-oxoG containing
duplex oligonucleotide with puriﬁed human enzymes includ-
ing APE1, Pol b and DNA ligase IIIa (Figure 7). Addition of
APE1convertedthe20merfragmentcontaining30-8-oxoGinto
a 19mer (Figure 7, lane 2), which is observed as the 20mer
fragment after ﬁlling the gap by Pol b (Figure 7, lane 3) and
A
WCE PC-FI PC-FII -
0      2      5       2       5       2      5
20-8-oxoG
19-mer
B
20-8-oxoG
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16   17   18   19    20   21   22  23   24
APE1
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16   17   18   19   20   21  22   23   24
Extract, g
Fraction
Fraction
Extract, g
20-8-oxoG
44-mer
02 5
D
Figure 5. Partialpurificationof30-8-oxoGendprocessingactivityfromhuman
cell extracts using Phosphocellulose and gel filtration chromatography.
(A) Repair of the duplex oligonucleotide substrate containing 30-8-oxoG by
HeLa WCE. (B) HeLa WCE was loaded onto a Phosphocellulose column and
fractionswerestepelutedusing0.15M(PC-FI)and1M(PC-FII)KCl.250fmol
of the 30-8-oxoG nick containing duplex oligonucleotide substrate was incu-
bated with WCE or Phosphocellulose fractions (2 and 5 mg) in the absence of
dNTPs for 20 min at 37 C. Formamide loading dye was added and an aliquot
analysed by 20% denaturing PAGE and phosphorimaging. (C) Proteins from
PC-FII were further separated by gel filtration on a Superdex-75 column and
the fractions obtained were analysed for 30-8-oxoG activity using 250 fmol of
the 30-8-oxoG duplex oligonucleotide substrate by 20% denaturing PAGE
and phosphorimaging. (D) Aliquots of the fractions were also analysed by
SDS–PAGE and western blotting using APE1 antibodies.
B
20-8-oxoG
19-mer
- 20     21     20     21     20      21
Original
Fractions Mock I.D. I.D.
1         2       3       4      5       6       7
A
APE1
Fraction 20    21      20     21        20     21
Original
Fractions Mock I.D. I.D.
Fraction
Figure 6. Immunoprecipitation of APE1 from gel filtration fractions contain-
ing 30-8-oxoG end processing activity. (A) Fractions from gel filtration
chromatography containing 30-8-oxoG excision activity (fractions 20 and
21) were mock-immunodepleted and immunodepleted of APE1 using APE1
specific antibodies. Samples were analysed by SDS–PAGE and western blot-
ting using antibodies against APE1. (B) The original fractions, mock immu-
nodepletedandimmunodepleted fractions20 and 21 were testedfor 30-8-oxoG
activity using 250 fmol of the 30-8-oxoG containing duplex oligonucleotide.
Samples were incubated for 10 min at 37 C prior to the addition of formamide
loading dye and analysis by 20% denaturing PAGE and phosphorimaging.
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full-length repair product (Figure 7, lane 4).
DISCUSSION
Ionizing radiation and the misincorporation of 8-oxodGMP by
DNA polymerases can induce SSBs with terminal 30-8-oxoG
ends. However, several different repair mechanisms exist that
may potentially repair this lesion. Excision of 30-8-oxoG
ends by a DNA glycosylase is one potential repair pathway
however, previous reports on the removal of 30-end damaged
bases are conﬂicting as 30-end uracil residues are resistant to
cleavage by uracil-DNA glycosylase (8) whereas it has been
suggested that human endonuclease III would be able to excise
30-terminal dihydrouracil residues (16). OGG1 was discovered
as the major enzyme for the removal of 8-oxoG:C pairs in
DNA (17,18) although the emergence of NEIL proteins that
contain a wide substrate speciﬁcity (19–21) may serve as a
backup activity to OGG1, even though NEIL1 has a relatively
weakactivitytowards8-oxoG lesions incomparison toOGG1.
However, we found that the 30-8-oxoG lesion is resistant to
excision by OGG1, NEIL1 and NEIL2 even when a 10-fold
molar excess of DNA glycosylases has been used.
Repair of SSBs containing 30-8-oxoG lesions could proceed
by direct ligation by a DNA ligase, so that the 8-oxoG lesion
can then be processed by the BER pathway. Relatively little is
known about the ligation of SSBs containing 30-8-oxoG using
human DNA ligases, although it has been previously reported
that T4 DNA ligase can ligate oligonucleotide substrates con-
taining 30-8-oxoG ends (22). However, our studies using either
human DNA ligase I or IIIa demonstrated that the 30-8-oxoG
containing strand break is non-ligatable under physiological
conditions.
Another possible solution for the repair of 30-8-oxoG resi-
dues would involve DNA polymerase strand displacement
synthesis so that the 30-end would be moved downstream to
the lesion and 8-oxoG can be subsequently repaired by the
BER pathway. Previous reports suggest that phage T7 DNA
polymerase and E.coli polymerase I or II are able to undergo
primer extension from 30-8-oxoG lesions, although the reac-
tionsare generally inefﬁcient (9,22). DNA polymerase aand b
have also been shown to extend from 30-8-oxoG residues,
although with low efﬁciency (3) and in agreement with this
study our results show that Pol b is unable to efﬁciently extend
beyond 30-8-oxoG lesions.
We subsequently found that APE1 protein can excise
30-8-oxoG lesions and furthermore, APE1 activity is the pre-
dominant mechanism for excision of 30-8-oxoG lesions in
human cell extracts. This would then create a one nucleotide
gap substrate for gap ﬁlling and ligation by a DNA polymerase
and a DNA ligase, respectively. Correspondingly, we were
able to reconstitute the entire pathway with puriﬁed human
enzymes including APE1, Pol b and DNA ligase IIIa. APE1 is
knowntointeractwithXRCC1(23)andPolb(24)duringBER
and subsequently these interactions may be important during
the repair of 30-8-oxoG lesions initiated by APE1, for the
recruitment of Pol b and XRCC1-DNA ligase IIIa complex
that will restore DNA integrity.
Taken together,ourdatademonstratethatAPE1isthe major
activity involved in the repair of SSBs containing 30-8-oxoG
in human cell extracts. We have previously demonstrated that
APE1 is also the major activity in human cell extracts against
30-phosphoglycolate (14). Furthermore, APE1 has been shown
to contain 30-exonuclease activity for mismatched DNA bases
[for review see (25)]. These observations support the view that
APE1 may play a central role in the processing of SSBs con-
taining blocked 30-ends. Our data also predict that APE1 may
excise other 30-end modiﬁed nucleotides that are resistant to
cleavage by DNA glycosylases. Consistent with our results, it
was recently demonstrated that yeast cell-free extracts, as well
as puriﬁed Apn1, can excise 30-8-oxoG and that deletion of
both OGG1 coding for 8-oxoG-DNA yeast glycosylase and
APN1 coding for the major yeast AP endonuclease causes
a 46-fold synergistic increase in spontaneous mutation rate
(M. Saparbaev, personal communication).
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